» Articles » PMID: 18182040

Unprovoked Recurrent Venous Thrombosis: Prediction by D-dimer and Clinical Risk Factors

Overview
Publisher Elsevier
Specialty Hematology
Date 2008 Jan 10
PMID 18182040
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The aim of the study was to determine the predictive value of D-dimer measurement for unprovoked recurrent venous thrombosis and the influence of sex, age and type of first event (unprovoked or provoked).

Methods: Prospective cohort study of 272 patients with a first episode of venous thrombosis that was unprovoked or provoked by a non-surgical trigger.

Findings: The cumulative rate of unprovoked recurrence in patients with a positive D-dimer was 20% at 5 years [5.5/100 patient-years, 95% confidence interval (CI) 3.7-7.8] and in patients with a negative D-dimer 17% (4.1/100 patient-years, 95% CI 2.3-6.9). The rates are not different (hazard ratio 1.3, 95% CI 0.7-2.5). After adjustment for clinical risk factors a positive D-dimer result was significantly associated with an increased risk of unprovoked recurrent thrombosis (hazard ratio 2.0, 95% CI 1.01-3.9). The strongest indicator of risk of recurrence was male sex (hazard ratio 3.3 unadjusted and 2.9 after adjustment). The only determinant of D-dimer in a linear regression model was age (P < 0.001).

Conclusions: The analysis indicates that clinical risk factors confound the association between D-dimer and risk of recurrence and when adjusted for these confounders a positive D-dimer result is significantly associated with unprovoked recurrence. The clinical utility of D-dimer measurement in individual patients should be interpreted in conjunction with clinical risk factors.

Citing Articles

Elevated plasma complement factor H related 5 protein is associated with venous thromboembolism.

Iglesias M, Sanchez-Rivera L, Ibrahim-Kosta M, Naudin C, Munsch G, Goumidi L Nat Commun. 2023; 14(1):3280.

PMID: 37286573 PMC: 10247781. DOI: 10.1038/s41467-023-38383-y.


Risk of Recurrent Venous Thromboembolism in Selected Subgroups of Men: A Danish Nationwide Cohort Study.

Albertsen I, Konstantinides S, Piazza G, Goldhaber S, Larsen T, Sogaard M TH Open. 2022; 6(4):e378-e386.

PMID: 36452198 PMC: 9674434. DOI: 10.1055/a-1949-9404.


Predicting Recurrent Venous Thromboembolism in Patients With Deep-Vein Thrombosis: Development and Internal Validation of a Potential New Prediction Model (Continu-8).

Nagler M, van Kuijk S, Ten Cate H, Prins M, Ten Cate-Hoek A Front Cardiovasc Med. 2021; 8:655226.

PMID: 33889600 PMC: 8055939. DOI: 10.3389/fcvm.2021.655226.


Retrospective review of D-dimer testing for venous thrombosis recurrence risk stratification: is this a useful test in the real world?.

Wang J, Tacey M, Ho P J Thromb Thrombolysis. 2020; 49(4):562-571.

PMID: 32253709 DOI: 10.1007/s11239-020-02101-y.


D-dimer testing, with gender-specific cutoff levels, is of value to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: a post hoc analysis of the DULCIS study.

Palareti G, Legnani C, Antonucci E, Cosmi B, Poli D, Testa S Intern Emerg Med. 2019; 15(3):453-462.

PMID: 31691119 PMC: 7165144. DOI: 10.1007/s11739-019-02216-y.